Drug Shortage Report for ARIXTRA
| Report ID | 147305 |
| Drug Identification Number | 02245531 |
| Brand name | ARIXTRA |
| Common or Proper name | fondaparinux sodium injection (0.5 mL) |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | FONDAPARINUX SODIUM |
| Strength(s) | 2.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 PF Syringe |
| ATC code | B01AX |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-01-01 |
| Actual start date | |
| Estimated end date | 2022-01-15 |
| Actual end date | 2021-12-22 |
| Shortage status | Avoided shortage |
| Updated date | 2021-12-22 |
| Company comments | GR90683CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-12-22 | French | Compare |
| v3 | 2021-12-22 | English | Compare |
| v2 | 2021-10-15 | French | Compare |
| v1 | 2021-10-15 | English | Compare |
Showing 1 to 4 of 4